ArticleOncology reports2019

The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging.

Shengfei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.